Your browser doesn't support javascript.
loading
Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients.
Armas-López, Leonel; Piña-Sánchez, Patricia; Arrieta, Oscar; de Alba, Enrique Guzman; Ortiz-Quintero, Blanca; Santillán-Doherty, Patricio; Christiani, David C; Zúñiga, Joaquín; Ávila-Moreno, Federico.
Afiliación
  • Armas-López L; National University Autonomous of México (UNAM), Facultad de Estudios Superiores (FES) Iztacala, Biomedicine Research Unit (UBIMED), Lung Diseases And Cancer Epigenomics Laboratory, Mexico State, Mexico.
  • Piña-Sánchez P; Instituto Mexicano del Seguro Social (IMSS), Centro Medico Nacional (CMN) Siglo XXI, Unidad de Investigación Médica en Enfermedades Oncológicas (UIMEO), Molecular Oncology Laboratory, Mexico City, Mexico.
  • Arrieta O; National Cancer Institute (INCAN), Thoracic Oncology Clinic, Mexico City, Mexico.
  • de Alba EG; National Institute of Respiratory Diseases (INER) "Ismael Cosío Villegas", Mexico City, Mexico.
  • Ortiz-Quintero B; National Institute of Respiratory Diseases (INER) "Ismael Cosío Villegas", Mexico City, Mexico.
  • Santillán-Doherty P; National Institute of Respiratory Diseases (INER) "Ismael Cosío Villegas", Mexico City, Mexico.
  • Christiani DC; Harvard Medical School, Harvard School of Public Health, Department of Environmental Health, Boston, Massachusetts, USA.
  • Zúñiga J; National Institute of Respiratory Diseases (INER) "Ismael Cosío Villegas", Mexico City, Mexico.
  • Ávila-Moreno F; National University Autonomous of México (UNAM), Facultad de Estudios Superiores (FES) Iztacala, Biomedicine Research Unit (UBIMED), Lung Diseases And Cancer Epigenomics Laboratory, Mexico State, Mexico.
Oncotarget ; 8(40): 67056-67081, 2017 Sep 15.
Article en En | MEDLINE | ID: mdl-28978016

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: México

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: México